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Abstract 
            Studies worldwide indicate that oral enzyme therapy (OET) can prevent or reduce 
the side effects associated with standard oncology care.  Yet use of OET is not common 
in the United States.  The ultimate aim of the proposed project is to improve the quality 
of life of women with breast cancer who are on standard chemotherapy protocols.  
Achieving this goal can be facilitated by implementation of the proposed feasibility 
project designed to: (a) enhance the knowledge of oncology care providers and women 
with breast cancer on use of OET in conjunction with standard oncology care, (b) assess 
the attitudes of oncology care providers and women with breast cancer regarding use of 
OET, and (c) establish relationships with providers in the oncology care community and 
groups for women with breast cancer.    
            An educational program entitled “Enzyme Nutrition in Oncology Care” was 
developed and implemented in the project setting.  Six programs were conducted with 
women with breast cancer, their support persons and the general public.  Four programs 
were conducted with oncology care provider groups.  An enzyme knowledge test was 
administered to program attendees in a pre-test/post-test fashion.  Analysis of scores on 
the post-test when compared to the pre-test demonstrate that the knowledge base 
regarding oral enzyme therapy use in conjunction with standard oncology care was 
increased for all educational program attendees.  Additionally scores reveal a favorable 
shift for use of OET in conjunction with standard oncology care and patient participation 
in clinical trials.  By conducting educational programs with four oncology care provider 
groups, relationships were established with all of the oncology care provider groups in 
the project setting.  
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Introduction 
       The National Center for Complementary and Alternative Medicine (NCCAM) 
defines complementary and alternative medical (CAM) approaches as “a group of diverse 
medical and health care systems, practices and products that are not generally considered 
a part of conventional/allopathic medicine” (NCCAM, 2010).  Complementary and 
alternative (CAM) approaches are grouped into categories which include: (a) natural 
products, (b) mind and body medicine, and (c) manipulative and body-based practices.  
Data from the 2007 National Health Interview Survey (NHIS) reveals that adults in the 
United States spent 33.9 billion out-of-pocket dollars on visits to CAM practitioners and 
purchases of CAM products, classes and materials (Nahin, et al, 2009).  Additionally the 
2007 estimates place overall prevalence of CAM use at 38.3 percent (83 million) of 
adults in the United States (Nahin, et al, 2009).   
    Patients seeking relief from the side effects of cancer therapy often turn to 
approaches outside of the conventional medical model.  The debilitating side effects of 
radiation and chemotherapy, e.g. nausea/vomiting, sore mouth, loss of appetite, pain, 
fatigue, hair loss, and numbness/tingling in fingers and toes, often are not adequately 
managed with conventional medical approaches.  A survey conducted with patients 
receiving care at M.D. Anderson Cancer Treatment Center in Houston, Texas, revealed 
CAM use was common in this patient population (Richardson, et al, 2000).              
      Use of CAM approaches in lieu of or in conjunction with conventional oncology 
care appears to be absent in clinical oncology literature published in the United States.  
Peer-reviewed articles from journals such as the American Journal of Clinical Oncology 
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and the Oncology Nursing Forum center predominantly on managing standard oncology 
care, such as radiation and chemotherapy.     
       Most CAM approaches use natural substances that are not proprietary and to date 
have not been patented by the U.S. Patent Office.  Research and development dollars are 
not typically spent on CAM products or approaches.  Clinical research on CAM 
approaches is required for sustainability of their use in the current evidence-based 
medical culture.  Meanwhile clinical research on CAM approaches is requisite for 
sustainability of their use in the current evidence-based medical culture.  This poses a 
dilemma regarding ways to generate evidence-based CAM approaches to treat the side 
effects of cancer therapy but sets the stage for a well-designed clinical research trial to 
evaluate the use of CAM approaches in conjunction with or in lieu of conventional 
oncology care.  
       Additionally medical and nursing school curricula do not include course offerings 
on the use of CAM approaches as treatment for health problems making their use in 
practice challenging.  Based on this lack of education, health care providers are 
challenged to develop an in-depth understanding of CAM approaches.  The challenge 
must be met with the same scientific rigor and discipline that has successfully served the 
biomedical model.     
            Extensive clinical experience has been gained by this doctoral student with 
patients who use CAM approaches.  In particular experience has been gained with 
patients who use oral enzyme therapy (OET) in combination with their standard oncology 
care.  Observations of clinical outcomes for these patients reveal reduction in the 
severity, and at times prevention, of many of the expected side effects associated with 
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standard oncology care.  Anecdotal observations regarding fatigue, pain, and 
numbness/tingling of the hands and feet suggest a benefit for patients with cancer who 
use OET in conjunction with their standard oncology care.  Healing damaged skin 
secondary to radiation therapy has been observed in patients who use OET.   
           An informal survey among a network of CAM practitioners who recommend OET 
for their patients receiving chemotherapy or radiation therapy reveals similar anecdotal 
observations to those cited above.   
            Yet anecdotal observations do not stand up to scrutiny in today’s evidence-based 
health care culture and CAM approaches must be evaluated in a scientific manner using 
well-designed clinical trials.   
            This Doctor of Nursing Practice Clinical Scholarship Project (CSP) is the first 
step in beginning to quantify data about the effect of OET in a group of women with 
breast cancer.  The population of women with breast cancer is meaningful for two 
different reasons.  The first is personal since my sister died from recurrent, metastatic 
breast cancer.  The second is epidemiologic in that one in eight women will be diagnosed 
with breast cancer over the course of her lifetime (ACS, 2010).  The review of the 
literature presented later in this paper reveals that the use of OET may prevent, reduce or 
eliminate the side effects associated with standard oncology care.  A reduction or even 
prevention of the side effects associated with standard breast cancer chemotherapy 
regimens may improve the quality of life for women with breast cancer.  Preventing, 
reducing or eliminating side effects may result in decreased cost of care for breast cancer 
patients undergoing chemotherapy. 
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Project Rationale 
    This doctoral student conducted a clinical scholarship project (CSP) regarding the 
use of OET in conjunction with standard oncology care.  The CSP aims to uncover the 
strengths and weaknesses of a proposed venture to determine the interest from the 
community regarding their involvement in a research study on the topic of OET.  This 
CSP allowed for identification of opportunities and threats presented by the 
implementation of such a research study and the process of conducting such a research 
study at some time in the future. 
    In Southwest Missouri there is a noticeable lack of use of complementary and 
alternative medicine (CAM) approaches in health care practice.  This fact suggests that 
conventional health care providers are not recommending the use of OET.  The proposed 
CSP may enhance future efforts in conducting clinical research that includes OET. 
Intent of the Clinical Scholarship Project 
    The major component of the proposed CSP was the development and 
implementation of an educational program entitled “Enzyme Nutrition in Cancer Care”.  
The educational program was presented to both oncology care providers and women with 
breast cancer.  Goals of presenting the educational program include: (a) increased 
knowledge on use of OET to prevent/reduce the side effects of standard oncology care, 
and (b) assessment of the attitude of oncology care providers and women with breast 
cancer regarding OET use.   
       The intent of the proposed CSP was to evaluate outcomes of presenting “Enzyme 
Nutrition in Cancer Care”.   Several issues have been identified that may impact 
implementation of OET in conjunction with standard oncology care.  Those issues 
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included: (a) observed lack of implementation of CAM approaches in the project region, 
(b) an observed lack of knowledge among health care providers and the general public 
regarding CAM approaches, and (c) the prevailing conventional medical culture. The 
proposed CSP was designed to: (a) enhance the knowledge of oncology care providers 
and women with breast cancer on use of OET in conjunction with standard oncology 
care, (b) assess the attitudes of oncology care providers and women with breast cancer 
regarding OET use, and (c) establish relationships with the oncology care community and 
with groups for women with breast cancer.    
Stakeholders Identified for the Clinical Scholarship Project    
       In Springfield, Missouri, there are two large oncology care groups. Oncology 
Hematology Associates is affiliated with Cox Health Systems, and Hematology and 
Oncology Clinics is affiliated with Mercy Medical Missions.  Each health system has a 
dedicated cancer resource center: C.H. “Chub” O’Reilly Cancer Center at Mercy Medical 
Missions, and Hulston Cancer Center at Cox Health Systems.  Each of these two large 
health care systems in Springfield has a dedicated breast cancer center.  Additionally the 
feasibility project included Skaggs Cancer Center in Branson (approximately 35 miles 
south of Springfield) and Central Care Cancer Center in Bolivar (approximately 40 miles 
north of Springfield).   
       Another group includes members of each of the oncology care groups mentioned 
above who joined forces for purposes of conducting clinical research. This joint venture 
is known as the Cancer Research for the Ozarks (CRO).  While their research efforts 
focus on standard oncology care protocols, inclusion in the stakeholder discussion is 
warranted as CRO faces challenges and barriers in conducting clinical research.  This 
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doctoral student anticipates similar challenges and barriers for conducting clinical 
research on CAM approaches.   
   Additional stakeholders for this CSP included women with breast cancer who 
attend support group meetings in the study setting.  A cursory survey revealed two such 
groups that are active at the time of project implementation.      
Conceptual Framework 
       Mior, Barnsley, Boon, Ashbury and Haig (2010) designed a qualitative study 
aimed at promoting interprofessional collaboration between physicians and chiropractors 
in a community-based primary care setting in Ontario, Canada.  The resultant framework 
yielded processed-based factors that fell into three categories: (a) communication, (b) 
practice parameters, and (c) service delivery (Mior, et al, 2010).  The emergent 
framework focused on patient care and attributes promoting a trusting relationship 
between chiropractors (CAM providers) and physicians in a primary care community 
setting. 
       Delineated in the framework are activities to enhance communication.  
Attendance at formal meetings, which include regular educational programs to share 
knowledge about relevant aspects of evidence-based patient care, is promoted. Case study 
discussions are used as the educational format for facilitating discussion.  Informal social 
meetings are used for developing personal relationships and mutual trust and respect 
(Mior, et al, 2010).   
       The conceptual framework developed by Mior, et al, (2010) may help promote 
interprofessional collaboration not only between physicians and chiropractors, but also 
between other health care providers.  The conceptual framework developed by Mior, et 
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al, (2010) was selected for the CSP and is appropriate for CAM providers to begin 
establishing relationships with members of the conventional medical community and for 














Figure 1.  Framework focusing on patient care and promoting collaboration (Mior,et al). 
Review of the Literature 
Literature on Enzyme Therapy in Oncology Care 
       Somewhat misunderstood, use of enzyme therapy struggles to gain a legitimate 
position in medical approaches in the United States.  There is limited literature on it in 
peer-reviewed oncology journals.  Yet the foundations of  modern enzyme therapy can be 
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“The Enzyme Treatment of Cancer and its Scientific Basis” (Beard, 1911).  Extending 
early science on enzyme therapy came when James B. Sumner was awarded the Nobel 
Prize in Chemistry for his efforts to crystallize the enzyme urease from jack bean meal 
and identified it as a protein (Sumner, 1946; Zanker, 2001).   
       Plant extracts with high proteolytic enzyme activity have been used for a long 
time in traditional medicine (Leipner & Saller, 2000).  Therapeutic use of proteolytic 
enzyme therapy is based partially on scientific studies and partially on empirical 
evidence. Modern enzyme therapy often includes pancreatic enzymes.  Clinical studies to 
evaluate the efficacy of proteolytic enzyme therapy in oncology have mostly been 
conducted with an enzyme preparation that contains both plant and pancreatic enzymes.   
       German researchers designed an epidemiological retrospective cohort analysis 
with parallel groups to evaluate the impact of OET given complementary to standard 
oncology care therapy in patients with all stages of colorectal cancer.  In a cohort of 1242 
patients with colorectal cancer, 616 received complementary treatment with OET while 
626 had not received OET.  Patients who had undergone primary surgery numbered 
1162.  For primary surgical patients, 526 received adjuvant chemotherapy and 218 
received radiation therapy.  Median follow-up time for the OE group was 9.2 months and 
for the control group 6.1 months.  The primary test criterion of efficacy for the OET 
group was the multivariate effect size of the changes from baseline of the disease-related 
and therapy-related signs and symptoms of nausea, vomiting, changes in appetite, 
stomach pain or stomach disorder, tiredness, depression, memory or concentration 
disorder, sleep disturbance, dizziness, irritability, dyspnea at rest, dyspnea during activity, 
headache, tumor pain, cachexia, skin disorders and infections.  Safety of OET was 
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analyzed in terms of number and severity of adverse events, their duration, treatment and 
outcome.  Analysis revealed a significant reduction in disease-associated signs and 
symptoms in patients treated with OET.  Adverse reactions to chemotherapy and 
radiation therapy were diminished in all patients receiving OET.  Researchers concluded 
that treatment of colorectal cancer patients with adjuvant OET reduces the signs and 
symptoms associated with their disease process and reduces the adverse reactions 
associated with adjuvant standard oncology care therapies (Popiela, et al, 2001). 
       Researchers in India conducted a prospective, randomized clinical trial enrolling 
120 subjects undergoing radiation therapy for treatment of locally advanced, biopsy 
proven carcinomas of the cervix (Stages IIa, IIb or IIIb).  Patients received 50 Gy of 
external radiation therapy over a period of 5 weeks, followed by intra-cavitary 
brachytherapy of 20-30 Gy.  Sixty patients who were assigned to the test group received 
additional OET.  Patients were evaluated weekly for acute radiation therapy-related side 
effects and for an additional 8 weeks after the conclusion of their radiation treatment.  
Results of the study revealed that the maximum extent of acute radiation side effects was 
reduced in the enzyme group: a) skin reactions (mean 0.97 vs 1.68 in the control group, 
P<0.001); b) vaginal mucosa reactions (mean 0.55 vs 0.85, P=0.10); c) genitourinary 
symptoms (mean 0.93 vs 1.38, P<0.001); and d) gastrointestinal reactions (mean 1.12 vs 
1.30, P=0.12).  Sum scores during treatment were noted to be significantly less in the 
enzyme treated patients.  All observed side effects of radiation therapy were of lower 
intensity in the enzyme group.  Based on study findings the researchers concluded that 
for patients with locally advanced cancer of the cervix, OET was found to be effective in 
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significantly reducing radiation side effects such as genitourinary symptoms, 
subcutaneous changes and reactions of the vaginal mucosa (Dale, et al, 2001).   
       In Germany an epidemiological, multicenter retrospective cohort study was 
conducted to evaluate the impact of OET given complementary as a post-operative care 
approach with breast cancer patients receiving standard anti-neoplastic therapy.  A cohort 
of 2339 breast cancer patients undergoing surgical intervention and radio, chemo- or 
hormonal therapy were studied in 216 centers.  Of the 2339 patients, 1283 received 
complementary OET and 1056 patients did not.  The median follow-up team for the test 
group was 485 days and for the control group 213 days.  The endpoint of the study was to 
evaluate if complementary OET can reduce typical disease- or therapy-associated signs 
and symptoms (e.g. gastrointestinal symptoms, mental symptoms, dyspnea, headache, 
tumor pain, cachexia, skin disorders, infections and side effects associated with standard 
oncology care protocols) in patients with breast cancer.  Analysis of data revealed for all 
symptoms, except tumor pain, the adjusted mean improvement in symptom scores was 
larger in the test group than in the control group.  The adjusted difference was statistically 
significant for all symptoms except tumor pain and infections.  Results demonstrate that 
the typical disease- and therapy-associated signs and symptoms for breast cancer patients 
on complementary OET during postoperative treatment were significantly less (Beuth, et 
al, 2001).   
       Patients with invasive breast cancer receiving adjuvant or palliative chemotherapy 
between 2005 and 2006 who had at least two further cycles of chemotherapy scheduled 
were studied by researchers in Austria.  The hypothesis was that specific toxicities of 
individual patients would be reduced by the use of OET.  The majority of the 57 
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consecutive patients received palliative chemotherapy.  Researchers concluded that OET 
administered consistent with the study protocol had only a marginal influence in patients 
with breast cancer who had experienced grade two toxicity in the preceding cycle and 
who had received two additional identical cycles of chemotherapy (Petru, et al, 2010). 
       Researchers in the Slovak Republic utilized OET adjunctively with standard 
combination chemotherapy for patients with multiple myeloma.  A cohort of 265 patients 
with multiple myeloma stages I-III was treated consecutively in two parallel groups.  An 
OET regimen was given to 166 patients receiving standard chemotherapy while 99 
patients receiving standard chemotherapy served as the control group.  Primary endpoint 
for this study was disease-specific survival.  Secondary endpoints were response to 
therapy, duration of the first response and side effects.  Survival analysis was performed 
using the Kaplan-Meier method and a multivariate analysis was done with the Cox 
proportional hazards model.  Analysis revealed significantly higher overall response rates 
and longer duration of remissions for the OET group.  Additive therapy with OET for 
greater than six month duration decreased the hazard of death for patients at all stages of 
disease by approximately 60 percent.  Observation time was not adequate to estimate the 
median survival for patients with Stage I and Stage II disease; for Stage III patients 
median survival was 47 months in the control group versus 83 months in the OET group    
(Sakalova, et al, 2001).  Based on these findings, a prospective, randomized Phase III 
study was initiated in the United States under an orphan drug designation.  A search 
regarding the outcome of the aforementioned Phase III study entitled “Chemotherapy 
With or Without Wobe-Mugos E in Treating Patients with Stage II or III Multiple 
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Myeloma” [protocol ID MUCOS-MU 699-501, NCT 00014339] reveals recruitment has 
closed but final results are not available. 
Discussion 
       Review of this limited scientific literature supports use of OET in conjunction 
with standard oncology care as a safe and efficacious approach for the prevention or 
reduction of side effects observed from such therapy.  Observation of conventional 
oncology care approaches in the United States reveals use of OET is not commonplace.  
A potential explanation includes a lack of knowledge of oncology care providers with 
regard to OET.  A lack of prospective, randomized, controlled clinical trials on the use of 
OET in the United States may be another factor. 
 Review of the Literature on Continuing Education Programs 
       A review of the literature supports the use of an educational program for 
achieving the ultimate aim of this clinical scholarship project.  Studies show that 
educational programs impact both knowledge and attitudes for both health care providers 
and patients.  Studies cited below demonstrate the impact of educational programs 
presented to both provider and patient audiences. 
       Researchers conducted a study to evaluate the impact of a continuing education 
course on general practitioner knowledge, attitude, practice approach and patient 
outcomes with regard to the diagnoses of depression and anxiety.  A case controlled 
before-and-after design was used with fourteen general practitioners who participated in 
the continuing education program.  Practitioners who participated in the educational 
program were matched with fourteen general practitioners who did not participate.  
Differences between the groups and pre- and post-test measurement of knowledge, 
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attitude and clinical practice were examined using t-tests and chi-square tests for 
categorical variables and analysis of covariance for continuous variables.  Analysis of the 
data resulted in statistically significant changes in the intervention group of general 
practitioner’s knowledge and attitude regarding the diagnoses of depression and anxiety.  
Findings reveal attendance at a continuing education program can result in a change in 
practitioner knowledge and attitudes (McCall, Clarke, and Rowley, 2004).    
   A randomized controlled trial (RCT) was conducted to investigate the 
effectiveness of, and satisfaction with, small-group problem-based learning (PBL) versus 
a didactic lecture approach for disseminating evidence-based guidelines on asthma 
management.  Both groups experienced a significant increase in asthma related 
knowledge.  However PBL participants rated the perceived educational value of the 
program higher than did lecture participants (4.36 vs 3.93, P=.04) suggesting a more 
satisfactory learning experience.  Small group sessions, such as the PBL sessions used for 
this study, with participants sitting around a conference table may be preferable for 
disseminating clinical information to providers in the context of busy schedules and 
multiple responsibilities (White, et al, 2004). 
       Investigators sought to evaluate the effectiveness of a community based cervical 
cancer education program targeting both nurses and women living in rural areas of 
Honduras.  Radio programs were used to deliver the education program to the general 
public.  There were short spot messages that aired at fifteen or thirty minute intervals and 
an hour long message that aired twice a day.   At the nurses’ monthly educational session 
a forty-five minute education program was presented.  Structured interviews were used to 
evaluate the knowledge level regarding the need for screening pap smears among women 
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in the community before and after the radio broadcasts.  Response score increases were 
statistically significant for all knowledge categories evaluated for the women in the 
community who had attended the educational program via radio broadcasts.   Pre- and 
post-intervention questionnaires were administered to the nurses.  Statistically significant 
differences were observed in all knowledge categories evaluated for the nurses who 
attended the program.  Researchers concluded that in developing countries, inexpensive 
community-based educational programs delivered via radio broadcasts and lecture 
presentations can increase cervical cancer knowledge and impact health care behavior 
(Perkins, et al, 2007). 
       A study was conducted to evaluate the effectiveness of a nurse-initiated education 
program on osteoporosis prevention behaviors.  A randomized controlled study was 
conducted with seventy-six women.  A forty-five minute educational program on the four 
osteoporosis prevention behaviors was conducted with the thirty-eight women 
randomized into the intervention group.  Two follow-up phone consultations were 
conducted within the month following the program.  Pre-, post- and follow-up data were 
compared regarding attitudes and adoption of osteoporosis behaviors.  Results of analysis 
revealed statistically significant increases for adoption of each of the behaviors by the 
intervention group when compared to the control group (Chan and Ko, 2006).  
Discussion 
        Central to the CSP design is to present an educational program to members of the 
oncology care community and to women with breast cancer.  Using this approach is well 
supported based on review of the literature and consistent with the conceptual framework 
described by Mior, et al, (2010).  Continuing education programs delivered in a fashion 
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similar to the proposed program have been shown to have an impact on the knowledge 
and attitudes of both health care providers and the general public.  Impact on attitudes 
and enhanced knowledge regarding the use of OET in conjunction with standard 
oncology care may benefit future clinical research efforts.   
The Educational Program 
       An educational program entitled “Enzyme Nutrition in Oncology Care” regarding 
the use of enzyme therapy in oncology care was developed (see Appendix A) and 
implemented to facilitate the stated aim of this clinical scholarship project.  Topics 
covered in the educational program include: (a) an overview of enzyme therapy, (b) the 
history of enzyme therapy use in oncology care, (c) review of the science regarding 
enzyme therapy used in conjunction with standard oncology care protocols, and (d) 
presentation of anecdotal observations regarding the use of OET with oncology patients. 
       A Power- point presentation format was used to aid presenting the educational 
program.  The same program was used with both oncology care provider groups and 
groups of women with breast cancer, their support persons and the general public.  While 
the program was the same, during the presentation emphasis was placed on different 
aspects tailored to the target audience.  The physiology and biochemistry of proteolytic 
enzymes was emphasized for provider groups while clinical experiences with OET were 
emphasized for women with breast cancer, their support persons, and the general public. 
       Evaluating effectiveness of the educational program was accomplished by use of 
a pre-test/post-test design.  A multiple item knowledge test, containing multiple choice 
and true/false items, was developed to measure clinical knowledge about basic 
physiologic enzyme activity and the role of enzyme nutrition in oncology care (see 
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Appendix B).  The test was administered to participants prior to the educational program 
and again at the conclusion of the program; in a pre-test/post-test design.  Participant pre-
test/post-test scores were compared as a way of evaluating the effectiveness of the 
educational program.   
       Provider attitude and behavior was measured using a student-developed 
questionnaire specific to this clinical scholarship project (see Appendix C).  The 
questionnaire contains one yes/no item and three Likert-scaled items.  The questionnaire 
was administered in a pre-and post-program fashion.  Provider responses completed prior 
to the educational program are compared with their responses completed after the 
educational program.  Changes in provider attitude and clinical approach with regard to 
OET were evaluated by comparing these responses.  Provider willingness to support 
patient participation in a clinical research study using OET with standard oncology care 
was assessed as well.   
       Attitude and behavior of women with breast cancer, their support persons, and the 
general public were measured with a student-developed questionnaire using the same 
process used for the provider groups.  The questionnaire contains one yes/no item and 
three Likert-scaled items (see Appendix D).  A change in attitude and stated care 
approach with regard to OET for women with breast cancer, their support persons, or the 
general public were evaluated by comparing responses on the pre-program questionnaire 
with those on the post-program questionnaire.  Willingness to participate in a clinical 
research study using OET with standard oncology care was assessed as well. 
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IRB and HIPPA Issues 
       The proposed clinical scholarship project included implementation of an 
educational program on the use of OET in conjunction with standard oncology care.  A 
knowledge test and an enzyme use questionnaire were used as a part of the educational 
program.  No personal identifying information or health care information was collected 
during the project.  An IRB submission for exempt approval was initiated by this doctoral 
student and an exemption was granted in accordance with Title 5 Code of Federal 
Regulations Part 46.101b.  There are no identifiable HIPPA issues, given that no personal 
identifiers are used and no protected health information was collected from attendees. 
Setting and Participants 
       The setting for this feasibility project was the greater Springfield, Missouri, the 
location of this doctoral student’s clinical practice.  Springfield’s population is 
approximately 200,000 people.  A brief telephone survey conducted with the two large 
health care facilities in Springfield revealed an average of 600 – 650 women newly 
diagnosed with breast cancer annually.  The project setting was expanded to include 
Branson, Missouri and Bolivar, Missouri, both of which are approximately forty miles 
outside of Springfield.  Presence of a designated cancer center in these communities 
makes their inclusion in the feasibility project appropriate.  A brief telephone survey 
conducted with Bolivar revealed an average of 30-35 newly diagnosed women with 
breast cancer annually and telephone survey results for Branson revealed a similar 
number of women diagnosed with breast cancer annually. 
       Potential participants for the project’s educational program included any of the 
oncology care providers in the project setting and women with breast cancer, their 
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support persons, or the general public.  Staff members of local breast cancer screening 
programs, breast cancer support groups, breast cancer advocacy groups, and the 
American Cancer Society local office are also potential participants.  While the latter 
group are not typically involved in clinical decision making regarding treatment they are 
included in this project because they provide support to women diagnosed with breast 
cancer. 
Implementation Activities 
       Activities to move the project forward to completion commenced upon receiving 
approval for the proposed CSP by this doctoral student’s committee.  After IRB review 
and approval implementation activities were launched. The main activities included: (a) 
identifying resources used by women with breast cancer in the project setting, (b) 
identifying educational resources used by women with breast cancer in the project 
setting, (c) identifying group or meeting resources utilized by women with breast cancer 
in the project setting, (d) determining the ability to interface with women with breast 
cancer as a part of/during group or meeting formats, (e) determining availability of 
facilities to conduct the proposed educational program with women with breast cancer, 
(f) identifying educational resources used by oncology care providers in the project 
setting, (g) determining the ability to interface with oncology care providers in the project 
setting, (h) identifying appropriate facility use to conduct the educational program with 
oncology care providers, (i) disseminating information about the scheduled educational 
programs for women with breast cancer, (j) conducting the proposed educational program 
with women with breast cancer, their support persons and the general public, (k) 
disseminating information about the scheduled educational programs for oncology care 
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providers, and (l) conducting the proposed educational program with oncology care 
providers.   
       Identifying resources used by women with breast cancer in the project 
setting – to include general resources, educational resources and support group 
resources.  Face-to-face, phone, and internet inquiries were conducted in the project area 
regarding the resources available to/used by women with breast cancer.  There is a cancer 
resource center at the Hulston Cancer Center located in a building on the Cox Health 
System campus.  Individuals with cancer in the project setting, including women with 
breast cancer, can browse through the resource center and find information about groups, 
meetings and support services.  There is a general retail store located in this center with 
products that may be of interest and benefit to individuals undergoing standard oncology 
care, e.g. hats, scarves, special garments, or items to be of assistance to caregivers e.g. 
personal hygiene assistance devices, safety devices.  Also found in this resource center is 
a wide variety of reading materials/books on the subject of dealing with cancer.  A 
monthly calendar of support and group meetings can be found on the information desk in 
the resource center.    
       Typically on the third Thursday of the month there is a breast cancer support 
group meeting held in the evening at the Hulston Cancer Center.  However, with October 
being breast cancer awareness month, the Pink Ribbon Rally and Luncheon for Breast 
Cancer was held on October 22nd instead of the usual support group meeting.  
Informational flyers with dates, times and locations of the OET educational program 
were handed out at this event.  
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       Extensive networking and investigation revealed that there are no other breast 
cancer support groups meeting in the project setting at the present time.  The Breast 
Cancer Foundation of the Ozarks sponsors a Young Survivors group in Texas County, 
Missouri.  However a phone conversation with the coordinator of this program revealed 
that active group meetings that had taken place for about the last year.   
       Contact with the American Cancer Society (ACS) office in the project setting 
revealed that they do not sponsor any support group activities for breast cancer patients.  
However the local ACS does sponsor the Reach to Recovery Program.  The Reach to 
Recovery Program was implemented to assist individuals diagnosed with breast cancer 
navigate the diagnosis and treatment.  The program pairs a trained volunteer who is a 
breast cancer survivor in a one-on-one relationship with a woman who is newly 
diagnosed with breast cancer.  Conversations with ACS staff members revealed that a full 
day Reach for Recovery Program training class was scheduled for October 29, 2011.  A 
request was made by this doctoral student to be able to attend the training course as an 
observer.  This request was denied. 
       Determining the ability to interface with women with breast cancer and 
availability of facilities to conduct the educational program with them.  Lack of 
consistent group and support meetings for women with breast cancer in the project setting 
resulted in then need to expand activities for successful implementation of the 
educational program.  Facilities in the project setting appropriate for conducting the 
educational program were surveyed in regard to availability and costs.  After extensive 
surveying it was determined that the most acceptable settings, based on availability, 
accessibility, and cost were community rooms at the local public libraries.   
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       For the public libraries in Springfield and Bolivar, Missouri, use of community 
rooms was restricted to not-for-profit activities.  Even though presentation of the 
educational program was a not-for-profit venture, scheduling of rooms at the libraries 
could not be accomplished without a not-for-profit organization sponsoring the proposed 
educational program.  A not-for-profit health ministry, High Way Ministries, founded by 
this doctoral student in 2003 became the sponsoring organization for the proposed 
educational program. 
       Identifying educational resources used by oncology care providers.  Phone 
contact was made with oncology care provider groups in the project setting.  Practice 
managers and/or advanced practitioners from each of the groups were queried as to the 
continuing educational approaches used most often for dissemination of information 
regarding patient care approaches.  This inquiry revealed that a common approach used 
across multiple practice settings was a breakfast or lunch presentation in the office.  
Other approaches included attendance at grand rounds, journal review/journal club 
activities and attendance at continuing education programs.   
       Determining the ability to interface with oncology care providers and 
availability of facilities to conduct the educational program with them.    Contact was 
made with each of the oncology care provider groups mentioned in this document as 
stakeholders with the exception of CRO, as members there were represented in other 
stakeholder groups.  Another contact was made with the American Cancer Society Office 
in the project setting.   
       An educational program was conducted with each of the stakeholders with the 
exception of the ACS, whose administrative representative declined the invitation to 
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participate in the project.  All of the oncology provider groups determined that the best 
setting to conduct the educational program was in the oncology clinic or oncology 
infusion center so as to minimize the disruption of the work flow of the providers who 
might possibly attend the program. 
       Disseminating information about the scheduled educational programs for 
women with breast cancer.  Implementation of the CSP was planned to coincide with 
national breast cancer awareness month.  It was discovered that the Breast Cancer 
Foundation of the Ozarks was sponsoring and promoting “Breastfest” on October 1st.  
Event activities included mini-educational programs on topics related to the experience of 
breast cancer.  Several health and wellness organizations in the project setting served as 
both vendors and presenters.  The event was attended with the express purpose of 
distributing flyers to event vendors and attendees with dates, times and locations that the 
OET educational program was going to be held for women with breast cancer, their 
support persons, and the general public.  Nearly fifty flyers were distributed at this event.     
       Community resources that offered avenues to announce/promote the educational 
program were explored.  It was determined that three local publications had a community 
announcement service available that would allow publishing, at  no cost, information 
about the educational program to include the following: (1) dates, times and locations of 
presentations, (2) a brief description of information that would be presented, and (3) the 
sponsoring organization for the presentations.  As noted earlier in this document, use of 
community rooms at local public libraries required that the presentations be sponsored by 
a not-for-profit organization and they required that all flyers and postings contain the 
name of the sponsoring organization.  Announcements were placed in the available 
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community publication resources three weeks in advance of scheduled presentations of 
the educational program.  Flyers were placed on community boards at local health food 
stores, specialty book stores, and organic markets. 
       Conducting the educational program with women with breast cancer, their 
support persons and the general public.  Eight sessions were scheduled in which to 
present the educational program to women with breast cancer, their support persons and 
the general public.  Programs were presented in community rooms at public libraries in 
the project setting.  Programs were conducted in Bolivar, Springfield and Branson.  
Attendance at the programs varied from location to location.  Larger attendance was 
observed at programs held in Springfield where the general population is about six times 
the population of each of the two smaller municipalities.   
       Presentation of the educational program varied from approximately forty minutes 
to sixty minutes.  The longer times were observed in programs with the larger attendance 
numbers as there was more discussion during the presentation.  A question and answer 
session was conducted at the conclusion of each program which lasted as long as 
necessary to insure all questions had been adequately addressed.   
       Disseminating information about the scheduled educational programs for 
oncology care providers.  Reliance on administrative staff members of the oncology 
care provider groups was the vehicle used to disseminate dates and times for presentation 
of the continuing education program to the oncology providers.  Avenues reported to 
have been used included: (a) break room bulletin/announcement boards, (b) flyers posted 
on entry/exit doors, (c) flyers posted in restrooms, (d) flyers placed in staff internal 
mailboxes, and (e) intra and inter-departmental email communications.   
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       Conducting the educational program with oncology care providers.  A total of 
four presentations of the educational program were scheduled.  Each of the oncology care 
provider groups had conference rooms in or near the clinical services area making it 
convenient for providers to attend the educational program.  Presentation of the 
educational program varied from approximately thirty minutes to forty minutes.  A 
question and answer session was conducted at the conclusion of each program which 
lasted as long as necessary to insure all questions had been adequately addressed. 
Deviations from Proposed Plan and Rationale 
       The original project design was to conduct the educational program with 
oncology care provider groups and women with breast cancer.  Project implementation 
activities quickly revealed the lack of routine/recurrent gatherings of women with breast 
cancer.  The decision to launch study activities during national breast cancer awareness 
month did lead to the ability to market the proposed program to women with breast 
cancer.   However it was determined that attendance at the educational programs would 
have to be open to support persons of women with breast cancer and the general public in 
order to make the activity a meaningful one, thus reaching a wider audience.  This was 
not part of the original design but the inclusion of these additional individuals in no way 
altered the educational program.  Presenting the educational program to the wider 
audience may potentially have a greater impact on knowledge of OET in the study 
setting.  In retrospect, it would have been logical to include support persons of women 
with breast cancer as a part of the original target audience.  Often these individuals are 
the guiding force for women with breast cancer who navigate complex treatment 
modalities. 
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Barriers and Challenges 
       Based on observed lack of implementation of CAM approaches by oncology care 
providers in the project setting, lack of support for implementation of same in 
conjunction with standard oncology care was anticipated.  Such lack of support could 
have an adverse effect on implementation of the clinical scholarship project.  Initial 
inquiry regarding scheduling of the educational program was received with responses 
such as: (a) not sure the providers will have time, (b) don’t think the providers will be 
interested in an education program on the use of enzyme nutrition, and (c) not sure the 
providers would be in favor of patients taking any supplements during their course of 
standard oncology therapy.  Permission to conduct the educational program was obtained 
only after introducing the topic of the possibility of a funded research study in the future.  
Once the topic of potential clinical research was introduced greater receptivity was 
observed.  The ability to schedule the educational program with oncology care provider 
groups suggests partially overcoming the anticipated barrier that the prevailing 
conventional medical culture may adversely affect implementation of the proposed 
feasibility project.   
       The challenge of time was not anticipated to be such a barrier when designing the 
project.  In the oncology care provider groups, the individual scheduling the educational 
program was mindful about the amount of time involved for the educational activity.  The 
scheduler wanted to insure that there would be no inconvenience to the personal 
schedules of the providers and that there would be no negative impact on delivery of 
patient care services.  This challenge was overcome by scheduling the oncology care 
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provider programs early in the morning when providers would typically be arriving at the 
clinical site and just prior to beginning of patient care activities.   
       Conducting the educational program took, on average, fifty minutes when 
presented to the public audience, the provider programs needed to be streamlined for 
delivery in thirty minutes.  Accomplishing this task was facilitated by the fact that the 
educational preparation of providers was such that the language and physiologic concepts 
were not foreign and did not require in depth explanation.  This allowed for progression 
through aspects of the program at a much faster pace than for the general public.  That is 
not to say that questions that arose from providers were not adequately addressed; in fact 
they were addressed as they arose during the presentation.  However more questions 
arose from the general public attendees regarding the physiologic concepts presented 
during the program. 
Clinical Scholarship Project Outcomes 
Analysis of Data 
       As outlined in the Educational Program Section of this paper, enzyme knowledge 
tests and enzyme use questionnaires were administered prior to the educational program 
and then again after the program.  Pre-program enzyme use questionnaire responses and 
enzyme knowledge test scores were compared to the post-program responses and scores.  
Discussion is summarized separately for the general public and the oncology care 
providers.  Table 1 presents a summary of the results for general public participants and 
Table 2 presents a summary of the results for oncology care provider participants. 
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Table 1:  General Public Participants (N=36) % of Participants 
Knowledge test - total increased scores from pre-test to post-test 69%* 
Use Questionnaire # 2: selected a higher number on the post-program survey 
for the Likert-scale response question with regard to their likelihood of taking 
OET along with chemotherapy 
40%** 
Use Questionnaire # 3: selected a lower number on the  post-program Likert-
scale response question with regard to their likelihood of stopping OET if 
their health care provider recommended they do so 
40%** 
Use Questionnaire # 4: selected a higher response on the post-program Likert-
scale response question with regard to their likelihood of participating in a 
research study where OET was used in conjunction with standard 
chemotherapy 
40%** 
*31% of general public participants scored 100% on the pre-test, resulting in no change between pre-test and 
post-test scores                                                                                                                                                                  
**46% of general public participants did not demonstrate a change because their initial responses were in the 
affirmative 
 
       For the general public enzyme knowledge test, analysis of pre-test/post-test scores 
reveals increased scores for 69% of participants.  It should be noted that the remaining 
31% of general public attendees scored 100% on the pre-test so there was no change in 
post-test scores.  Based on these findings the educational program was effective in 
increasing the general public attendees’ knowledge of the use of OET.  
       The enzyme use survey administered in a pre-program/post-program fashion was 
used to evaluate if the educational program could impact participant’s attitudes regarding 
use of OET in conjunction with oncology care protocols.  Analysis of the responses on 
the pre-test survey revealed that 23% of participants were already taking OET.  Analysis 
of the remaining data will not include data from these participants as their current use of 
OET is demonstrative of their attitude with regard to its use.  Comparison of the data with 
respect to the remaining participants reveals the following:  (a) 40% selected a higher 
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number on the post-program survey for the Likert-scale response question with regard to 
their likelihood of taking OET along with chemotherapy, (b) 40% selected a lower 
number on the  post-program Likert-scale response question with regard to their 
likelihood of stopping OET if their health care provider recommended they do so, and (c) 
40% of participants selected a higher response on the post-program Likert-scale response 
question with regard to their likelihood of participating in a research study where OET 
was used in conjunction with standard chemotherapy.  These responses suggest the 
educational program impacted the attitude of participants with regard to OET.   
       It should be noted that 46% of participants did not demonstrate a change on the 
three enzyme use survey Likert-scale questions as their initial responses were at the end 
of the scale demonstrating an affirmative attitude regarding: (a) use of OET in 
conjunction with standard chemotherapy, (b) not stopping OET use with chemotherapy if 
their health care provider advised them to do so, (c) and opting to participate in a research 
study where OET was used in conjunction with standard chemotherapy.  
Table 2:  Oncology Care Provider Participants (N=32) % of Participants 
Knowledge test - total increased scores from pre-test to post-test 100% 
Use Questionnaire # 2: selected a higher number on the post-program survey 
for the Likert-scale response question with regard to their likelihood of  
recommending the use of OET with chemotherapy 
90% 
Use Questionnaire # 3: selected a higher number on the  post-program Likert-
scale response question with regard to their likelihood of not advising a 
patient to discontinue OET in conjunction with chemotherapy 
70% 
Use Questionnaire #4:selected a higher response on the post-program Likert-
scale response question with regard to their likelihood of supporting a 
patient’s participation in a research study where OET was used in conjunction 
with standard chemotherapy 
80% 
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     For the oncology care provider enzyme knowledge test, analysis of pre-test/post-
test scores reveals increased scores for 100% of participants.  Based on these findings the 
educational program was effective in increasing the oncology care providers’ knowledge 
of the use of OET.  Unlike analysis of the general public knowledge test results, no 
oncology care provider scored 100% on the pre-test.  A possible explanation for this 
phenomenon is that general public attendees self-selected to attend an education program 
on a CAM modality as they have sought or are seeking solutions to health care problems 
outside of the conventional medical approach.   
       The enzyme use survey administered in a pre-program/post-program fashion was 
used to evaluate if the educational program could impact participant’s attitudes regarding 
use of OET in conjunction with standard oncology care protocols.  Analysis of the 
responses on the pre-test survey revealed that 0% of the oncology care providers were 
already discussing the use of OET in conjunction with standard oncology care 
approaches.  Analysis of the data with respect to oncology care providers’ responses 
reveals the following:  (a) 90% selected a higher number on the post-program survey for 
the Likert-scale response question with regard to their likelihood of  recommending the 
use of OET with chemotherapy, (b) 70% selected a higher number on the  post-program 
Likert-scale response question with regard to their likelihood of not advising a patient to 
discontinue OET in conjunction with chemotherapy, and (c) 80% of participants selected 
a higher response on the post-program Likert-scale response question with regard to their 
likelihood of supporting a patient’s participation in a research study where OET was used 
in conjunction with standard chemotherapy.  These responses suggest the educational 
program positively impacted the attitude of oncology care providers with regard to OET.   
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Discussion of Findings 
       In order to adequately discuss the findings cited above, a review of the 
anticipated outcomes for the feasibility project is presented below: 
       Short Term Outcomes. 
         ° Increase awareness of the scientific body of knowledge regarding use of oral  
 enzyme therapy in conjunction with oncology care.       
         ° Increase oncology care provider and women with breast cancer’s knowledge of  
 oral enzyme therapy use in conjunction with standard oncology care.     
         ° Initiate networking activities with oncology care providers and groups of women 
 with breast cancer.  
        Intermediate Outcome.   
         ° Establishment of relationships with providers in the oncology care    
community and groups of women with breast cancer by overcoming anticipated  
and identified barriers. 
       Long Term Outcome. 
         ° Improve the quality of life of women with breast cancer by maximizing the  
 relationships developed through this feasibility project which may facilitate 
    implementation of a clinical research study using OET in conjunction with   
   standard breast cancer chemotherapy. 
      Short term outcomes.  Review of the change in scores from pre-test to post-test 
administration of the enzyme knowledge test demonstrates that the short term outcome 
was met.  The enzyme knowledge test encompassed information gleaned from the 
scientific body of knowledge regarding use of OET alone or in conjunction with standard 
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oncology care.  Questions and conversations that took place in conjunction with 
presenting the educational program demonstrate increased awareness of OET in addition 
to the increased knowledge demonstrated by testing.  These evaluations and observations 
hold for both the oncology care provider groups and group that included women with 
breast cancer, their support persons, and the general public.  
       As previously described, networking activities were central to the successful 
implementation of the clinical scholarship project.  Networking activities were conducted 
with oncology care provider groups and groups of women with breast cancer.  However 
networking activities with women with breast cancer did not take place in the context and 
setting as anticipated. 
       Intermediate outcome.  A challenge existed for establishing relationships with 
groups of women with breast cancer.  Group meetings thought to be in existence based on 
initial assessment of resources in the project setting were discovered to be for the most 
part inactive.  The one support group that would typically have met during the most time 
intensive period of project implementation altered their group meeting format for 
alternate breast cancer awareness activities. 
       Long term outcome.  The length of time for project implementation and 
evaluation does not allow for evaluation of the stated long term outcome.  Expanding 
upon and nurturing of the relationships established with the oncology care provider 
community during project implementation may prove to facilitate the desired long term 
outcome.  Additional requirement for achievement of the long term outcome would 
include a funding source for a clinical research study to evaluate the use of OET in 
conjunction with standard oncology care. 
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 Cost to Benefit Analysis and Ethical Concerns 
Cost for implementing the clinical scholarship project included: (a) costs of 
printed materials, writing instruments, and miscellaneous office materials for organizing 
study documents; (b) cost of laptop computer and video projector to conduct the 
education program; and (c) cost of light refreshments for program participants. It is 
difficult to conduct an actual cost/benefit analysis regarding this CSP since the project 
did employ some minimal costs yet the benefit of an educational program is not able to 
be determined in such a small project.   
       One of the issues examined in this clinical scholarship project was the 
establishment of relationships between this doctoral student and the oncology care 
provider community.  There was no relationship evaluation tool or instrument selected 
for use as a part of this project, making it impossible to analyze data to come to a 
conclusion for this question.  Personal observation and reflection regarding the stated 
question reveals:  (a) use of a CAM approach, specifically OET, in conjunction with 
standard oncology care for prevention/reduction of side effects was favorably received 
and (b) this doctoral student, as a CAM provider, was favorably received by the members 
of the provider community as well as the public.  In the project setting’s conventional 
medical culture, these observations are priceless. 
      Ethical concerns surrounding implementation of the project included the potential 
lack of concern by conventional medical providers for women with breast cancer.  That 
concern was based on the observed lack of implementation in the project setting of CAM 
approaches that have evidence-based efficacy.  Implementation and evaluation of the 
clinical scholarship project does not allow for an opinion or a conclusion to be formulated 
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with regard to this ethical concern.  Only case reviews and time will allow for evaluation 
of the impact of this feasibility project with regard to the ethical concerns in the project 
setting.   
Application to Practice 
       As previously stated, implementation of the CSP will not result in any change in 
clinical practice for this doctoral student.  Protocols using OET are presently in use in this 
doctoral student’s practice setting.  Findings of this clinical scholarship project indicate 
an increased knowledge base and a change in oncology care provider attitudes 
surrounding the use of OET with cancer patients.   Additionally implementation of the 
CSP launched relationship building between the oncology care community and this 
doctoral student.  Perhaps a result of this relationship building will facilitate 
implementation of clinical research using OET in conjunction with standard oncology 
care.  Furthering the science on use of OET in conjunction with standard oncology care 
here in the United States may result in better quality of life for women with breast cancer 
by prevention, reduction, or elimination of the side effects of chemotherapy.  
       While the focus population of this project was women with breast cancer, benefits 
of OET in conjunction with standard oncology care have been observed with a wide 
range of cancer types and therapies.  Future projects may focus on the use of OET with 
individuals diagnosed with other types of cancer.  A project design focused on women 
with breast cancer, implementing of the project to coincide with national breast cancer 
awareness month, and establishment of relationships with the oncology care community 
may enhance this doctoral student’s ability to co-manage oncology patients and conduct 
clinical research.   
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       The application of findings of this CSP outside of the project setting is not 
anticipated.  The project was designed, implemented and evaluated specifically for a 
given oncology care community.  Perhaps the application of this project to nursing 
practice will be forthcoming in the form of publications that may stem from designing, 
implementing, and evaluating this clinical scholarship project. 
Impact of the Clinical Scholarship Project on Evaluation of the DNP Role 
       A case can be made for representation of some aspect of each of the eight 
Essentials of Doctoral Education for Advanced Nursing Practice by designing, 
implementing, and evaluating the feasibility project.  However a stronger correlation of 
project activities to four of the essentials is observed.  The discussion that follows will 
explore those corollaries.   
       A review of the essentials of doctoral education for advanced nursing practice 
reveals that development of this project is grounded in the first essential: scientific 
underpinnings for practice.  According to AACN (2006), to achieve the highest level of 
nursing practice the DNP program prepares the graduate to integrate nursing science with 
knowledge from ethics, the biophysical, psychological, analytical, and organizational 
sciences.  Exploration of literature from the organizational sciences ultimately facilitated 
successful design, implementation and evaluation of this clinical scholarship project 
(Asprey, 2004).  Concepts of a pilot study to determine if such a project is feasible are 
found in the nursing literature (Polit & Beck, 2004, Zust, 2000). 
       The ultimate goal of this CSP was to facilitate the conduct of future clinical work.  
Future clinical work would be linked directly to the third essential: clinical scholarship 
and analytical methods for evidenced-based practice.  With respect to this essential, a 
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correlation cannot be made between conducting this CSP and the tasks that AACN 
delineates for the graduate of a DNP program since.  Correlation cannot be made as this 
doctoral student finds the seven tasks outlined for this essential limit the role of an 
advanced practice nurse.   
       Given the wide range of provider types represented in the oncology care 
community this project encompasses the sixth essential: interprofessional collaboration 
for improving patient and population health outcomes.  According to AACN (2006), the 
DNP program prepares the graduate to use leadership skills with both intraprofessional 
and interprofessional teams to create change in health care.  Conducting the clinical 
scholarship project resulted in development of interprofessional relationships.  The 
primary object of establishing such relationships is to enhance patient care outcomes and 
when possible by the addition of CAM approaches with standard oncology care.    
       Developing, implementing and evaluating this project serves as the hallmark of 
the eighth essential: advanced nursing practice.  Of the seven tasks delineated for this 
essential, conducting the feasibility project most closely relates to the second task:  
design, implement, and evaluate therapeutic interventions based on nursing and other 
sciences.  Undertaking the clinical scholarship project is the first step on the journey to 
enhance patient outcomes by implementing a CAM approach proven to prevent, reduce 
or eliminate the side effects of standard oncology care.   
Influence on Practice 
       The culmination of this doctor of nursing practice education is the further shoring 
up of a solid clinical foundation for delivery of advanced practice activities.  The 
experience of the clinical scholarship project allowed this doctoral student to make 
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inroads into a community of providers that often consider CAM providers as outsiders.  
Relational foundation and a view of collegiality can only stand to accelerate the goal of 
conducting clinical research studies on the use of CAM approaches in conjunction with 
standard oncology care.  More importantly, relationships established with members of the 
oncology care community have paved the way for greater acceptance of CAM approach 
use by patients with cancer.  Such action may have a positive impact on patient outcomes 
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Appendix A 
Oral Enzyme Therapy Educational Program Outline 
1.   Introduction  
 
2.   Pre-test/Survey   (unique identifier – middle initial and house number – with a capital A)     
 
3.   Overview of enzyme therapy   - a nutritional therapy 
 a)     role of enzymes in the body 
  i.    role of enzymes in the digestive system  (demonstration with food) 
  ii.   role of enzymes in the immune system 
  iii.  role of enzymes in the body 
 b)    historical overview of enzyme use in cancer care 
  
4.    Overview of the Literature 
 a)     study 1 – OET, colorectal cancer 
 b)     study 2 – OET, cervical cancer  
 c)     study 3 – OET, breast cancer 
 d)    study 4 – OET, breast cancer 
 e)    study 5 – OET, multiple myeloma  (emphasis on remission and survivability) 
 
5.   Anecdotal observations, questions and answers 
 a)     case study examples – breast cancer  (pain, energy, wound healing, anemia) 
 
6.  Post-test/Survey   (unique identifier – middle initial and house number – with capital B)     
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Appendix B 
Enzyme Knowledge Test 
Identifier:_________________      Location:_________________ 
 
Please answer the following questions (place a check mark on the line next to your answer): 
1.  Digestive dysfunction is a risk factor for cancer. 
___ True 
___ False 
2.  Which of the following are actions of proteolytic enzymes?  
___ A.  reduce tumor size 
___ B.  digest proteins 
___ C.  decrease inflammation 
___ D.  reduce the toxic effects of chemotherapy and radiation 
___ E.  prevent metastasis (spread of cancer) 
___ F.  facilitate detoxification 
3.  Enzymes taken by mouth are destroyed in the stomach by hydrochloric acid. 
___ True 
___ False 
4.  Protein is used in which of the following physiologic activities? 
___ A. energy 
___ B.  growth and repair 
___ C. maintenance of homeostasis 
5.  Use of enzyme therapy can increase survivability for cancer patients? 
___ True 
___ False 
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Appendix C 
Provider Enzyme Questionnaire 
Identifier:_________________      Location:_________________ 
 
Please answer the following questions (place a check mark or circle your answer): 
1.  Do you presently discuss the use of oral enzyme therapy with patients receiving 
chemotherapy? 
___ Yes 
___ No  
If the answer to #1 above is No, please answer questions below – thank you.   
2.  With your current knowledge regarding oral enzyme therapy, what is the likelihood that you 
would recommend oral enzyme therapy to your patients receiving chemotherapy?  
   0              1              2              3              4              5             6              7              8              9              10 
Would Not                                                                                                  Would 
Recommend                        Recommend 
 
 
3.  With your current knowledge regarding oral enzyme therapy, if a patient reported using oral 
enzyme therapy along with their chemotherapy would you advise them to stop taking them? 
    0              1              2              3              4              5             6              7              8              9              10 
 Would Advise                                                                     Would Not 
To Stop          Advise To Stop 
 
 
                      
4.  With your current knowledge regarding oral enzyme therapy, what is the likelihood that you 
would support your patient participating in a research study using oral enzyme therapy 
adjunctively with chemotherapy?  
    0              1              2              3              4              5             6              7              8              9              10 
Would Not                                                                                                                                            Would 
Support          Support 
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Appendix D 
Enzyme Use Questionnaire 
Identifier:_________________      Location:_________________ 
Please answer the following questions (place a check mark or circle your answer): 
 
1.  Are you presently taking any oral enzyme therapy? 
___ Yes 
___ No 
If the answer to #1 above is No, please answer questions below – thank you.   
 
2.  With your current knowledge regarding oral enzyme therapy, what is the likelihood that you 
would use enzyme therapy along with your chemotherapy?  
  0              1              2              3              4              5             6              7              8              9              10 
Would Not                                                                                                                                           Would     
Use                Use 
 
3.  With your current knowledge regarding oral enzyme therapy, if you were taking enzyme 
therapy and your health care provider advised you to stop them what is the likelihood you 
would you stop them? 
  0              1              2              3              4              5             6              7              8              9              10 
Would Not                                                                                                                                           Would       
Stop                         Stop 
     
                      
4.  With your current knowledge regarding oral enzyme therapy, what is the likelihood that you 
would participate in a research study using oral enzyme therapy with your chemotherapy?  
   0              1              2              3              4              5             6              7              8              9              10 
Would Not                                                                                                                                             Would 
Participate                        Not Participate 
